Isolation and Characterization of Phage-Displayed Single Chain Antibodies Recognizing Nonreducing Terminal Mannose Residues. 2. Expression, Purification, and Characterization of Recombinant Single Chain Antibodies†

Biochemistry ◽  
2007 ◽  
Vol 46 (1) ◽  
pp. 263-270 ◽  
Author(s):  
Wei Zhang ◽  
Ayano Matsumoto-Takasaki ◽  
Yu Kusada ◽  
Hiroyuki Sakaue ◽  
Keiko Sakai ◽  
...  

Biochemistry ◽  
2007 ◽  
Vol 46 (1) ◽  
pp. 253-262 ◽  
Author(s):  
Keiko Sakai ◽  
Yoshitaka Shimizu ◽  
Tomoki Chiba ◽  
Ayano Matsumoto-Takasaki ◽  
Yu Kusada ◽  
...  


Biochemistry ◽  
1996 ◽  
Vol 35 (40) ◽  
pp. 13212-13221 ◽  
Author(s):  
Hidetaka Kosako ◽  
Yoshiko Akamatsu ◽  
Naoya Tsurushita ◽  
Kyung-Kwon Lee ◽  
Yukiko Gotoh ◽  
...  


2002 ◽  
Vol 266 (1-2) ◽  
pp. 197-207 ◽  
Author(s):  
X.Sherry Chi ◽  
Yvonne Landt ◽  
Dan L Crimmins ◽  
Brian K Dieckgraefe ◽  
Jack H Ladenson






2005 ◽  
Vol 41 (1) ◽  
pp. 68-76 ◽  
Author(s):  
Jing Wang ◽  
Yu Shi ◽  
Yanqi Liu ◽  
Siyi Hu ◽  
Jun Ma ◽  
...  


2021 ◽  
Vol 12 ◽  
Author(s):  
Fang Zheng ◽  
Jinhong Zhou ◽  
Zhenlin Ouyang ◽  
Jiaxin Zhang ◽  
Xinyi Wang ◽  
...  

Nanobodies that are derived from single-chain antibodies of camelids have served as powerful tools in diagnostics, therapeutics and investigation of membrane receptors' structure and function. In this study, we developed a series of nanobodies by a phage display screening building from lymphocytes isolated from an alpaca immunized with recombinant mouse Kupffer cell receptor Clec4F, which is involved in pathogen recognition by binding to galactose and N-acetylgalactosamine. Bio-panning selections retrieved 14 different nanobodies against Clec4F with an affinity ranging from 0.2 to 2 nM as determined by SPR. Those nanobodies mainly recognize 4 different epitopes as analyzed via competitive epitope binning. By analysis of the radioactivity in each organ after injection of 99mTc labeled Clec4F nanobodies in naïve mice, we found that these nanobodies are targeting the liver. Furthermore, we performed a structural characterization at atomic resolution of two of the Clec4F nanobodies from different epitope groups, which revealed distinct features within the CDR2 and CDR3 regions. Taken together, we developed a series of nanobodies targeting multiple distinct recognition epitopes of the Kupffer cell-specific receptor Clec4F which may be useful for its structural and functional investigation as well as for use as molecular imaging and therapeutic agents.



Sign in / Sign up

Export Citation Format

Share Document